https://www.biopharma-reporter.com/Article/2023/01/06/CureVac-We-enter-2023-as-a-competitive-player-in-the-development-of-mRNA-therapies
0
0
1/9/23 at 10:04am
Organization
BioPharma-Reporter.com
Author
biopharma-reporter.com
38 words
0
Comments
Germany's CureVac announced positive preliminary data today from its ongoing Phase 1 clinical programs in COVID-19 and seasonal flu.
You are the first to view
Create an account
or login to join the discussion